1. 4CPS-191 How well do we cover pharmacogenetic recommendations included in the drugs' summaries of product characteristics (spcs)?. (2nd March 2018) Authors: García-González, X; Ortega, C; Ibañez, S; García, MI; Blanco, C; Salvador, S; Sanjurjo, M; López-Fernández, LA Journal: European journal of hospital pharmacy Issue: Volume 25(2018)Supplement 1 Page Start: A131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OHP-080 Use of Chemotherapy Near the End of Life. (12th March 2013) Authors: Martín, A; Ibañez, S; Blázquez, C; Muñoz, BM; Franco, MT; Fernández, AI; Rodriguez, M; Pérez, R; Encinas, C Journal: European journal of hospital pharmacy Issue: Volume 20(2013)Supplement 1 Page Start: A163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO.6.121 Epistemic injustice and educational needs for self-management in systemic lupus erythematosus. (27th September 2022) Authors: Fuentes-Silva, YJ; Solé, M; Acosta, C; Bermúdez Marrero, WM; Elera-Fitzcarrald, C; Ibañez, S; Reátegui-Sokolova, C; Vanegas, A; Pons-Estel, B; Drenkard, C Journal: Lupus science & medicine Issue: Volume 9(2022)Supplement 2 Page Start: A93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗